全文获取类型
收费全文 | 1781篇 |
免费 | 103篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 91篇 |
妇产科学 | 65篇 |
基础医学 | 177篇 |
口腔科学 | 45篇 |
临床医学 | 218篇 |
内科学 | 349篇 |
皮肤病学 | 17篇 |
神经病学 | 110篇 |
特种医学 | 278篇 |
外科学 | 210篇 |
综合类 | 25篇 |
预防医学 | 78篇 |
眼科学 | 23篇 |
药学 | 84篇 |
中国医学 | 10篇 |
肿瘤学 | 92篇 |
出版年
2023年 | 11篇 |
2022年 | 12篇 |
2021年 | 27篇 |
2020年 | 19篇 |
2019年 | 15篇 |
2018年 | 39篇 |
2017年 | 20篇 |
2016年 | 41篇 |
2015年 | 43篇 |
2014年 | 42篇 |
2013年 | 73篇 |
2012年 | 75篇 |
2011年 | 65篇 |
2010年 | 67篇 |
2009年 | 81篇 |
2008年 | 75篇 |
2007年 | 45篇 |
2006年 | 45篇 |
2005年 | 30篇 |
2004年 | 40篇 |
2003年 | 38篇 |
2002年 | 40篇 |
2001年 | 34篇 |
2000年 | 25篇 |
1999年 | 31篇 |
1998年 | 57篇 |
1997年 | 61篇 |
1996年 | 73篇 |
1995年 | 57篇 |
1994年 | 54篇 |
1993年 | 52篇 |
1992年 | 31篇 |
1991年 | 30篇 |
1990年 | 32篇 |
1989年 | 51篇 |
1988年 | 46篇 |
1987年 | 45篇 |
1986年 | 38篇 |
1985年 | 40篇 |
1984年 | 21篇 |
1983年 | 19篇 |
1982年 | 27篇 |
1981年 | 19篇 |
1980年 | 15篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 13篇 |
1976年 | 15篇 |
1975年 | 13篇 |
1969年 | 8篇 |
排序方式: 共有1892条查询结果,搜索用时 15 毫秒
1.
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
Dermoid cysts of the posterior cranial fossa in children. Report of nine cases and review of the literature 总被引:1,自引:0,他引:1
Dermoids of the posterior cranial fossa in children are rare. We report the clinical and pathological data on nine children with these lesions. A mean follow-up of 17.3 years after total removal confirms the excellent prognosis irrespective of whether the presenting symptom is meningitis or intracranial hypertension. A brief review of 39 published cases follows. 相似文献
4.
5.
6.
7.
8.
9.
B Daune M Batt R Hassen-Khodja G Avril J M Gagliardi J Amiel D Chevallier P Le Bas 《The Journal of cardiovascular surgery》1991,32(4):447-450
This prospective study was designed to determine the frequency and natural history of hydroureteronephrosis (HUN) after placement of an aortobifemoral vascular graft. A total of 30 patients were evaluated by the study protocol, which included: pre and postoperative biological kidney function tests, preoperative and early postoperative (14th day) intravenous pyelograms and a late (mean 18th month) urologic examination by renal ultrasonic tomography. Four asymptomatic, early cases of HUN were observed in the 57 ureters examined (7%); all four complications regressed in less than 30 days. No cases of symptomatic early or late HUN were observed in this series. Asymptomatic early HUN was a frequent complication in our series (7%) but its benign course does not justify systematic screening. These asymptomatic complications contrast with the symptomatic cases of early or late HUN reported in the literature which necessitated urologic and vascular investigations. 相似文献
10.